Anti-TNF biologics were the first biological therapies to significantly transform psoriasis treatment. Their approval in the mid-2000s marked a major turning point in psoriasis management and changed both physicians' and patients' expectations. Although some required intravenous infusions and others relatively frequent injections, the clinical improvements they achieved were remarkable and led to their widespread adoption in clinical practice.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Armstrong
Contact Armstrong, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack